BrainCancer.org presents our 10th video in our Brain Tumors 101 Series, “Radiation Therapy for the Brain Tumor Patient”. In this video, Dr. Charles Cobbs, Neurosurgeon and the Gregory Foltz Endowed Director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at Swedish Neuroscience Institute, Seattle, WA, describes what radiation therapy is and […]
Brain Tumors 101 Series: “MGMT Methylation in Glioblastoma Brain Tumors”
BrainCancer.org presents its 6th video in the Brain Tumors 101 series, “MGMT Methylation in Glioblastoma Brain Tumors”. This is Part 2 of 2 on MGMT Methylation. Topics discussed in this video include: Temozolomide and impact on MGMT Methylated and Unmethylated glioblastoma brain tumors, prognosis for unmethylated vs methylated brain tumors, and details on how to […]
Brain Tumors 101: After the Brain Tumor Diagnosis
https://youtu.be/FS7gbO5J4qU
Join Dr. Charles Cobbs for a Tour of The Ivy Center
For Seattle Brain Cancer Walk participants, teams and family members! Join Dr. Charles Cobbs, Neurosurgeon and Director of the Ivy Center for Advanced Brain Tumor Treatment for a tour of the state of the art Ivy Center at Swedish Neuroscience Institute in Seattle, Washington. Learn about the latest advancements and innovations in advanced brain tumor […]
11th Annual Seattle Brain Cancer Walk on May 6th, 2018!
Seattle Brain Cancer Walk 2018 Registration is now open for the the 11th annual Seattle Brain Cancer Walk which will take place on Sunday, May 6th. It is a national fundraising event to raise awareness about brain cancer and fund brain cancer research and clinical trials in the Pacific Northwest. It is a one-mile symbolic walk […]
CAR T-Cell Immunotherapy and Future Treatment Applications for Brain Tumor Patients
Dr. Charles Cobbs, Neurosurgeon and Director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at Swedish Neuroscience Institute in Seattle discusses CAR T-cell immunotherapy and its application to Brain Tumor treatment. For additional articles on this recent research for brain tumor patients, here are some additional links: https://www.cancer.gov/about-cancer/treatment/research/car-t-cells http://www.onclive.com/publications/contemporary-oncology/2014/august-2014/chimeric-antigen-receptor-car-t-cell-immunotherapy-for-leukemia-and-beyond https://www.cirm.ca.gov/agendas/02192015/car-t-cell-immunotherapy-challenges-and-opportunities-using-mature-or-stem-memory-t
Surgical Options After a Brain Tumor Diagnosis
Surgical Options After a Brain Tumor Diagnosis
May is Brain Tumor Awareness Month! #GOGRAYINMAY
May 1st marked the beginning of National Brain Tumor Awareness Month! Follow us on Facebook, Twitter, and Instagram to see the latest updates in this month to bring more awareness to this disease that impacts over 700,000 people currently in the United States alone. We will be using the hashtags #GoGrayInMay #BTAM for this month […]
Immunocellular Therapeutics Phase 3 ICT 107 Vaccine Clinical Trial for Glioblastoma Patients
ICT 107 is a vaccine for glioblastoma cancer stem cells. This vaccine was developed by a company called ImmunoCellular Therapeutics, (https://www.imuc.com ) primarily by researchers at Cedars Sinai in Los Angeles. https://virtualtrials.com/newsarticle.cfm?item=6107 This protocol has completed phase II testing and now it is open to a phase 3 randomized double blind control study for newly diagnosed glioblastoma. […]